BENITEC BIOPHARMA INC (BNTC) Stock Analyst Earnings Estimates
NASDAQ:BNTC - Nasdaq - US08205P2092 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 60K -40.00% | 70K 16.67% | 80K 14.29% | -100.00% | ||||
| EBITDA YoY % growth | N/A | N/A | N/A -4.82% | -25.092M -24.79% | -26.112M -17.90% | -36.248M -38.82% | 10.997M 130.34% | |
| EBIT YoY % growth | -13.6M -64.25% | -17.85M -31.25% | -19.08M -6.89% | -22.739M -17.87% | -29.1M -29.39% | -37.758M -29.75% | -50.527M -33.82% | |
| Operating Margin | -22,666.67% | -25,500.00% | -23,850.00% | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | -3.21 43.56% | -1.02 68.18% | -16.94 -1,561.08% | -5.32 50.66% | -1.43 82.90% | -2.19 -53.03% | -2.28 -4.27% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.36 78.16% | -0.38 71.18% | -0.48 -0.80% | -0.51 -54.96% | -0.42 -15.90% | -0.21 43.70% | -0.45 7.24% | -0.45 12.23% | -0.44 -6.88% | -0.45 -109.52% |
| Revenue Q2Q % growth | ||||||||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -8.678M -109.57% | -9.357M -68.66% | -11.145M -92.45% | -11.576M -34.45% | -12.027M -38.58% | -12.5M -33.58% | -12.872M -15.50% | -13.261M -14.56% | -13.666M -13.63% | -14.09M -12.72% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.33 87.50% | -0.79 | 0.46 | 57.97% |
| Q1 2025 Q2Q % growth | -0.48 82.61% | -0.56 | 0.08 | 14.44% |
| Q4 2024 Q2Q % growth | -1.32 53.41% | -0.50 | -0.82 | -165.05% |
| Q3 2024 Q2Q % growth | -1.64 39.71% | -0.80 | -0.84 | -105.87% |
| Q2 2024 Q2Q % growth | -2.64 22.35% | -0.40 | -2.24 | -563.65% |
| Q1 2024 Q2Q % growth | -2.76 65.46% | -0.52 | -2.24 | -430.57% |
| Q4 2023 Q2Q % growth | -2.83 73.12% | -3.29 | 0.46 | 14.01% |
| Q3 2023 Q2Q % growth | -2.72 60.00% | -3.47 | 0.75 | 21.57% |
| Q2 2023 Q2Q % growth | -3.40 -476.27% | -1.91 | -1.49 | -78.25% |
| Q1 2023 Q2Q % growth | -7.99 -1,188.71% | -3.21 | -4.78 | -149.07% |
| Q4 2022 Q2Q % growth | -10.54 -3,413.33% | -4.86 | -5.68 | -117.09% |
| Q3 2022 Q2Q % growth | -6.80 | -7.63 | 0.83 | 10.87% |
| Q2 2022 Q2Q % growth | -0.59 21.96% | % | ||
| Q1 2022 Q2Q % growth | -0.62 74.69% | % | ||
| Q4 2021 Q2Q % growth | -0.30 89.05% | % | ||
| Q2 2021 Q2Q % growth | -0.76 72.41% | -0.77 | 0.01 | 1.18% |
| Q1 2021 Q2Q % growth | -2.45 16.67% | -0.94 | -1.51 | -161.08% |
| Q4 2020 Q2Q % growth | -2.74 | -0.01 | -2.73 | -26,762.75% |
| Q3 2020 Q2Q % growth | -2.94 | -0.01 | -2.93 | -28,723.53% |
| Q2 2020 Q2Q % growth | -2.74 | -0.01 | -2.73 | -26,762.75% |
| Q1 2020 Q2Q % growth | -2.94 | -0.01 | -2.93 | -28,723.53% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | -100.00% | % | ||
| Q3 2024 Q2Q % growth | -100.00% | % | ||
| Q2 2024 Q2Q % growth | -100.00% | % | ||
| Q3 2023 Q2Q % growth | 54K 8.00% | 54K | % | |
| Q2 2023 Q2Q % growth | 10K -66.67% | 10K | % | |
| Q1 2023 Q2Q % growth | 9.69K | -9.69K | -100.00% | |
| Q1 2022 Q2Q % growth | -100.00% | % | ||
| Q4 2021 Q2Q % growth | 100.00% | % | ||
| Q3 2021 Q2Q % growth | -100.00% | % | ||
| Q2 2021 Q2Q % growth | -100.00% | 35.7K | -35.7K | -100.00% |
| Q1 2021 Q2Q % growth | 60K 100.00% | 66.3K | -6.3K | -9.50% |
| Q4 2020 Q2Q % growth | -40K -104.11% | 168.3K | -208.3K | -123.77% |
| Q3 2020 Q2Q % growth | 30K | 204K | -174K | -85.29% |
| Q2 2020 Q2Q % growth | 80K | 168.3K | -88.3K | -52.47% |
| Q1 2020 Q2Q % growth | 30K | 204K | -174K | -85.29% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 56.27% | 67.09% | 49.97% | 61.36% |
| Revenue | N/A | N/A | N/A | N/A |